These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 28449614)

  • 1. Poly(lactic-co-glycolic acid) nanoparticles for sustained release of allyl isothiocyanate: characterization, in vitro release and biological activity.
    Encinas-Basurto D; Ibarra J; Juarez J; Burboa MG; Barbosa S; Taboada P; Troncoso-Rojas R; Valdez MA
    J Microencapsul; 2017 May; 34(3):231-242. PubMed ID: 28449614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted Drug Delivery Via Human Epidermal Growth Factor Receptor for Sustained Release of Allyl Isothiocyanate.
    Encinas-Basurto D; Juarez J; Valdez MA; Burboa MG; Barbosa S; Taboada P
    Curr Top Med Chem; 2018; 18(14):1252-1260. PubMed ID: 30095054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell Line and Augument Cellular Uptake Study of Statistically Optimized Sustained Release Capecitabine Loaded Eudragit S100/PLGA(poly(lacticco- glycolic acid)) Nanoparticles for Colon Targeting.
    Pandey S; Vijayendra Swamy SM; Ubaid Ulla UM; Gupta A; Patel H; Yadav JS
    Curr Drug Deliv; 2017 Sep; 14(6):887-899. PubMed ID: 27538461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formulation and evaluation of tacrolimus-loaded galactosylated Poly(lactic-co-glycolic acid) nanoparticles for liver targeting.
    Mistry NP; Desai JL; Thakkar HP
    J Pharm Pharmacol; 2015 Oct; 67(10):1337-48. PubMed ID: 25944126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Docetaxel-loaded PLGA and PLGA-PEG nanoparticles for intravenous application: pharmacokinetics and biodistribution profile.
    Rafiei P; Haddadi A
    Int J Nanomedicine; 2017; 12():935-947. PubMed ID: 28184163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Formulation and process optimization of doxorubicin-loaded PLGA nanoparticles and its in vitro release].
    Li JL; Zheng CL; Liu JP; Zhu JB
    Yao Xue Xue Bao; 2013 May; 48(5):759-66. PubMed ID: 23888702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Poly aspartic acid peptide-linked PLGA based nanoscale particles: potential for bone-targeting drug delivery applications.
    Jiang T; Yu X; Carbone EJ; Nelson C; Kan HM; Lo KW
    Int J Pharm; 2014 Nov; 475(1-2):547-57. PubMed ID: 25194353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro IFN-α release from IFN-α- and pegylated IFN-α-loaded poly(lactic-co-glycolic acid) and pegylated poly(lactic-co-glycolic acid) nanoparticles.
    Feczkó T; Fodor-Kardos A; Sivakumaran M; Haque Shubhra QT
    Nanomedicine (Lond); 2016 Aug; 11(16):2029-34. PubMed ID: 27462975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Rapamycin-loaded poly (lactic-co-glycolic) acid nanoparticles for intraarterial local drug delivery: preparation, characterization, and in vitro/in vivo release].
    Miao LF; Yang J; Huang CL; Song CX; Zeng YJ; Chen LF; Zhu WL
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2008 Aug; 30(4):491-7. PubMed ID: 18795627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The targeting properties of folate-conjugated Pluronic F127/poly (lactic-co-glycolic) nanoparticles.
    Luo YY; Xiong XY; Cheng F; Gong YC; Li ZL; Li YP
    Int J Biol Macromol; 2017 Dec; 105(Pt 1):711-719. PubMed ID: 28716749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of Oxidized Low Density Lipoprotein-Induced Endothelial Cell Injury by DA-PLGA-PEG-cRGD Nanoparticles Combined with Ultrasound.
    Li Z; Huang H; Huang L; Du L; Sun Y; Duan Y
    Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28406431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High glycolic poly (DL lactic co glycolic acid) nanoparticles for controlled release of meropenem.
    Nandakumar V; Geetha V; Chittaranjan S; Doble M
    Biomed Pharmacother; 2013 Jun; 67(5):431-6. PubMed ID: 23583192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyaluronic acid-decorated poly(lactic-co-glycolic acid) nanoparticles for combined delivery of docetaxel and tanespimycin.
    Pradhan R; Ramasamy T; Choi JY; Kim JH; Poudel BK; Tak JW; Nukolova N; Choi HG; Yong CS; Kim JO
    Carbohydr Polym; 2015 Jun; 123():313-23. PubMed ID: 25843864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New approach to treating spinal cord injury using PEG-TAT-modified, cyclosporine-A-loaded PLGA/polymeric liposomes.
    Gao SJ; Liu Y; Wang HJ; Ban DX; Cheng SZ; Ning GZ; Wang LL; Chang J; Feng SQ
    J Drug Target; 2017 Jan; 25(1):75-82. PubMed ID: 27250819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel.
    Feng SS; Mei L; Anitha P; Gan CW; Zhou W
    Biomaterials; 2009 Jul; 30(19):3297-306. PubMed ID: 19299012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and characterization of doxorubicin-loaded poly(lactide-co-glycolide) nanoparticles as a sustained-release anticancer drug delivery system.
    Amjadi I; Rabiee M; Hosseini MS; Mozafari M
    Appl Biochem Biotechnol; 2012 Nov; 168(6):1434-47. PubMed ID: 22976852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conjugation of cell-penetrating peptides with poly(lactic-co-glycolic acid)-polyethylene glycol nanoparticles improves ocular drug delivery.
    Vasconcelos A; Vega E; Pérez Y; Gómara MJ; García ML; Haro I
    Int J Nanomedicine; 2015; 10():609-31. PubMed ID: 25670897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro schistosomicidal activity of the lignan (-)-6,6'-dinitrohinokinin (DNHK) loaded into poly(lactic-co-glycolic acid) nanoparticles against Schistosoma mansoni.
    Lima TC; Lucarini R; Luz PP; de Faria EH; Marçal L; Magalhães LG; Badoco FR; Esperandim VR; Molina EF; Laurentz RS; Lima RG; Cunha WR; Bastos JK; Silva MLA
    Pharm Biol; 2017 Dec; 55(1):2270-2276. PubMed ID: 29172838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel docetaxel chitosan-coated PLGA/PCL nanoparticles with magnified cytotoxicity and bioavailability.
    Badran MM; Alomrani AH; Harisa GI; Ashour AE; Kumar A; Yassin AE
    Biomed Pharmacother; 2018 Oct; 106():1461-1468. PubMed ID: 30119220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitamin E TPGS-emulsified poly(lactic-co-glycolic acid) nanoparticles for cardiovascular restenosis treatment.
    Feng SS; Zeng W; Teng Lim Y; Zhao L; Yin Win K; Oakley R; Hin Teoh S; Hang Lee RC; Pan S
    Nanomedicine (Lond); 2007 Jun; 2(3):333-44. PubMed ID: 17716178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.